相关实验视频
Updated: Aug 31, 2025

11:53
Substrate Generation for Endonucleases of CRISPR/Cas Systems
Published on: September 8, 2012
27.5K
克拉斯帕斯是一种CRISPRRNA引导的RNA激活蛋白酶
Chunyi Hu1, Sam P B van Beljouw2,3, Ki Hyun Nam4
1Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.
概括
通过向RNA结合激活CRISPR引导的酶 (Craspase),使其能够对抗Csx30的蛋白酶活性. 这种自我调节系统在目标RNA分裂后关闭蛋白酶功能.
科学领域:
- 分子生物学
- 生物化学
- 结构生物学
背景情况:
- 在CRISPR-Cas型III-E系统中,使用的是gRAMP/Cas7-11效应器复合体.
- 这种复合物与TPR-CHAT/Csx29结合,形成了Craspase酶.
- 克拉斯巴酶作为CRISPR引导的克拉斯巴酶,具有RNA向和蛋白酶活动.
研究的目的:
- 阐明在Craspase中目标RNA分裂和蛋白酶激活的机制.
- 为了确定Craspase的内源蛋白质基质.
- 了解Craspase系统的自我调节能力.
主要方法:
- 用冷电子显微镜 (cryo-EM) 来捕获Craspase的结构快照.
- 生物化学测定用于研究RNA结合,分裂和蛋白酶活性.
- 克拉斯帕斯的蛋白质基质的鉴定和特征.
主要成果:
- 在5'区域的目标导向RNA配对会取代一个关闭循环,从而启动构造变化.
- 这些变化将蛋白质酶催化二激活,并形成基质结合口袋.
- Csx30被确定为内源基质,由激活的Craspase特定地蛋白质化.
- 通过gRAMP抑制蛋白酶活性,而不是通过特定的RNA序列激活.
结论:
- 克拉斯帕斯是一种具有内在自我调节机制的新型RNA激活蛋白酶.
- 该系统对蛋白酶活性进行了精确的控制,与标RNA识别和分裂有关.
- 这项研究提供了关于CRISPR-Cas系统多样化的结构和机制见解.
相关概念视频
CRISPR
52.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.7K
CRISPR and crRNAs
17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
CRISPR/Cas9 Genome Editing
178
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
178
The Antiviral System of Bacteria and Archaea: CRISPR
108
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
108
Caspases
12.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.7K
RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K

